Table 6. The study’s inclusion and exclusion criteria.
The study’s inclusion and exclusion criteria are shown as supplemental Table 6.
Inclusion criteria | Age: ≥20 years |
Histologically diagnosed colorectal cancer. | |
Life expectancy: ≥3 months | |
Eastern Cooperative Oncology Group performance status: 0-1 | |
Neutrophil count: ≥1000/mm3 | |
Hemoglobin: ≥8.0 g /dL | |
Platelet count: ≥75,000/mm3 | |
Serum creatinine: ≤1.5 times the upper limit of normal | |
Total bilirubin: ≤2.0 mg /dL | |
Aspartate transaminase: ≤100 IU/L (≤200IU/L for patients with metastatic liver tumor) | |
Alanine transaminase: ≤100 International Unit (IU) / litre (L) (≤200IU/L for patients with metastatic liver tumor) | |
Exclusion criteria | Serious drug allergy |
Severe peripheral neuropathy | |
Active infection | |
Uncontrollable hypertension | |
Mechanical or paralytic bowel obstruction | |
Uncontrolled diabetes mellitus | |
Cirrhosis | |
Unstable ischemic heart disease | |
Multiple malignancy within the last five years | |
Ascites | |
Pleural effusion | |
Pericardial effusion | |
Uncontrolled diarrhea |